Literature DB >> 19091544

Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.

Valentina Carozzi1, Alessia Chiorazzi, Annalisa Canta, Norberto Oggioni, Alessandra Gilardini, Virginia Rodriguez-Menendez, Federica Avezza, Luca Crippa, Cecilia Ceresa, Gabriella Nicolini, Mario Bossi, Guido Cavaletti.   

Abstract

We have characterised for the first time the general and neurological side effects experienced when using a series of chronic non-lethal cisplatin + paclitaxel schedules in Wistar rats, selected according to our previous experience and the animals' maximum tolerated dose. At the pathological level, the use of combination schedules was definitely more toxic at the kidney and sternal bone marrow level than the single-agent schedules. At the neurophysiological examination based on the assessment of the nerve conduction velocity measurement in the tail nerve, we identified only one combination schedule that was more neurotoxic than the similar schedules based on single-agent administration. This observation was confirmed by the neuropathological examination performed on the sciatic nerve, dorsal root ganglia, ventral and dorsal roots. Our study supports the hypothesis that the general and, to a lesser extent, neurological effects of a combination of cisplatin and paclitaxel are different from those of the administration of both drugs as single agents. We believe that these models may be useful for testing neuroprotective strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091544     DOI: 10.1016/j.ejca.2008.10.038

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

2.  Alpha-lipoic acid and frataxin: a new indication for an old antioxidant?

Authors:  James W Russell
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

3.  Naringin Abrogates Cisplatin-Induced Cognitive Deficits and Cholinergic Dysfunction Through the Down-Regulation of AChE Expression and iNOS Signaling Pathways in Hippocampus of Aged Rats.

Authors:  Yassine Chtourou; Brahim Gargouri; Mohammed Kebieche; Hamadi Fetoui
Journal:  J Mol Neurosci       Date:  2015-04-21       Impact factor: 3.444

4.  APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER.

Authors:  Hyun-Suk Kim; Chunlu Guo; Eric L Thompson; Yanlin Jiang; Mark R Kelley; Michael R Vasko; Suk-Hee Lee
Journal:  Mutat Res       Date:  2015-06-26       Impact factor: 2.433

5.  Premature aging-related peripheral neuropathy in a mouse model of progeria.

Authors:  James R Goss; Donna Beer Stolz; Andria Rasile Robinson; Mingdi Zhang; Norma Arbujas; Paul D Robbins; Joseph C Glorioso; Laura J Niedernhofer
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

6.  Neuritin Promotes Bone Marrow-Derived Mesenchymal Stem Cell Migration to Treat Diabetic Peripheral Neuropathy.

Authors:  Zuo Zhang; Yuanzhi Liu; Jiyin Zhou
Journal:  Mol Neurobiol       Date:  2022-08-20       Impact factor: 5.682

7.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

8.  Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.

Authors:  Krystyna M Wozniak; James J Vornov; Ying Wu; Ying Liu; Valentina A Carozzi; Virginia Rodriguez-Menendez; Elisa Ballarini; Paola Alberti; Eleonora Pozzi; Sara Semperboni; Brett M Cook; Bruce A Littlefield; Kenichi Nomoto; Krista Condon; Sean Eckley; Christopher DesJardins; Leslie Wilson; Mary A Jordan; Stuart C Feinstein; Guido Cavaletti; Michael Polydefkis; Barbara S Slusher
Journal:  Cancer Res       Date:  2017-11-30       Impact factor: 12.701

9.  The preventive effect of oxytocin to Cisplatin-induced neurotoxicity: an experimental rat model.

Authors:  Tulay Akman; Levent Akman; Oytun Erbas; Mustafa Cosan Terek; Dilek Taskiran; Aydin Ozsaran
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

10.  Protection of trigonelline on experimental diabetic peripheral neuropathy.

Authors:  Ji-Yin Zhou; Shi-Wen Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.